Newsmeme!
Discover News you didn't know existed
Central Nervous System (Cns)
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Targacept Scientists Make Multiple Presentations at Society for Neuroscience Supporting the Potential of NNR ...
Published November 20, 2008, 5:55 am, Business Wire via Yahoo! Finance
WINSTON-SALEM, N.C.----Targacept, Inc. , a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics , today announced that its scientists recently made several presentations at the 38th annual meeting of the Society for Neuroscience .
Memory Pharmaceuticals Achieves Enrollment Goal For Phase 2 Study Of MEM 3454 In Cognitive Impairment Associated With ...
Published November 20, 2008, 3:08 am, Medical News Today
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced that it has achieved the enrollment goal for its Phase 2 trial of R3487/MEM 3454, its lead alpha-7 nicotinic receptor agonist, in cognitive impairment associated with schizophrenia (CIAS). The Company has randomized 212 patients in the Phase 2 trial, triggering a $5.0 million payment from its partner Roche.
PAION Announces Successful Completion Of Phase I Study With The Sedative/Anaesthetic CNS 7056
Published November 19, 2008, 12:09 pm, Medical News Today
The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8; London AIM: PAI) today announces that it has successfully completed a Phase I study with its intravenous sedative/anaesthetic CNS 7056.
Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With ...
Published November 19, 2008, 3:05 am, PR Newswire via Yahoo! Finance
Triggers $5 Million Payment from Roche-
PAION Announces Successful Completion of Phase I Study with the Sedative/Anaesthetic CNS 7056
Published November 18, 2008, 10:30 pm, Business Wire via Yahoo! Finance
AACHEN, Germany & CAMBRIDGE, United Kingdom----The biopharmaceutical company PAION AG today announces that it has successfully completed a Phase I study with its intravenous sedative/anaesthetic CNS 7056.
Accera Will Launch Axona, New Approach to Managing Alzheimer's Disease, in 2009
Published November 18, 2008, 7:00 am, PR Newswire via Yahoo! Finance
Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, will launch Axona in the United States for Alzheimer's disease in the first quarter of 2009.
StemCells, Inc. Closes $20 Million Equity Financing
Published November 18, 2008, 4:30 am, Business Wire via Yahoo! Finance
PALO ALTO, Calif.----StemCells, Inc. announced today that it has closed the sale of 13,793,104 units to certain institutional investors at a price of $1.45 per unit, for gross proceeds of $20.0 million.
High Growth Reported for the World Pharmaceuticals Market Brief
Published November 18, 2008, 3:22 am, Business Wire via Yahoo! Finance
NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
Tremendous Potential for Fibromyalgia Pharmaceuticals in Europe
Published November 17, 2008, 6:34 am, PR Newswire via Yahoo! Finance
With no available therapy for the treatment of fibromyalgia syndrome , pharmaceutical companies have shown great interest in coming up with possible recommendations and therapies for treatment.
Progenics Announces Wyeth Has Received RELISTOR Approval in Australia
Published November 17, 2008, 5:00 am, Business Wire via Yahoo! Finance
TARRYTOWN, N.Y.----Progenics Pharmaceuticals, Inc. , today announced the Therapeutic Goods Administration division of the Australian Government has approved the registration of RELISTOR® for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care when response to laxative therapy has not been sufficient.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |